Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dynavax Technologies Corp (NASDAQ:DVAX)

5.65
Delayed Data
As of 3:59pm ET
 -0.10 / -1.74%
Today’s Change
3.20
Today|||52-Week Range
18.96
+43.04%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close5.75
Today’s open5.76
Day’s range5.50 - 5.80
Volume817,748
Average volume (3 months)1,306,849
Market cap$266.0M
Dividend yield--
Data as of 3:59pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)+10.15%
Earnings growth (this year)+29.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+172.67%
P/E ratioNM
Price/Sales13.77
Price/Book2.49

Competitors

 Today’s
change
Today’s
% change
ZGNXZogenix Inc+0.30+2.80%
OCULOcular Therapeutix I...+0.49+5.21%
MTNBMatinas BioPharma Ho...-0.04-1.39%
ZYNEZynerba Pharmaceutic...+0.03+0.14%
Data as of 4:14pm ET, 04/27/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$11.0M
Annual profit (last year)-$112.4M
Net profit margin-1,018.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts